Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study

BACKGROUND: This study aimed to evaluate sickle-cell disease (SCD) treatment patterns and economic burden among patients prescribed hydroxyurea (HU) in the US, through claims data. METHODS: SCD patients with pharmacy claims for HU were selected from the Medicaid Analytic Extracts (MAX) from January...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nirmish, Bhor, Menaka, Xie, Lin, Halloway, Rashid, Arcona, Steve, Paulose, Jincy, Yuce, Huseyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794855/
https://www.ncbi.nlm.nih.gov/pubmed/31619251
http://dx.doi.org/10.1186/s12955-019-1225-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794855/
https://www.ncbi.nlm.nih.gov/pubmed/31619251
http://dx.doi.org/10.1186/s12955-019-1225-7

Ejemplares similares